The role of Primary Care Practitioner (PCP) in managing Inflammatory Bowel Disease (IBD) patients during COVID 19 Era

IF 1.6 4区医学 Q3 PRIMARY HEALTH CARE

Primary Health Care Research and Development Pub Date : 2020-01-01 DOI:10.15761/HPC.1000201

F. Ingravalle, G. Casella, A. Ingravalle, C. Monti, E. Santambrogio, F. Bonetti, A. Limonta

{"title":"The role of Primary Care Practitioner (PCP) in managing Inflammatory Bowel Disease (IBD) patients during COVID 19 Era","authors":"F. Ingravalle, G. Casella, A. Ingravalle, C. Monti, E. Santambrogio, F. Bonetti, A. Limonta","doi":"10.15761/HPC.1000201","DOIUrl":null,"url":null,"abstract":"Introduction: The Covid-19 epidemic started in late 2019 from China. Since then, it has spread all over the world. SARS-CoV-2 infection poses a new challenge for the health systems of the countries involved, which have diverted all efforts to contain the pandemic spread, penalizing the management of patients with chronic diseases. Also, the activity of IBD units was limited and restricted to severe patients to avoid virus spreading. Aim: The aim of the present review is to summarize and to report the earliest evidence regarding the novel managing strategies for IBD patients, in primary care. Method: A review of the main database of scientific publications was conducted, regarding Covid-19 and the management of the patient with IBD in primary care. Results: Several strategies have proven their efficacy. Among these, the most promising are telehealth and patient education (“shielding education”). These two interventions can monitor safely patient’s health and reduce the infection risk in IBD patient. Discussion: Nowadays, limited data in present scientific literature does not show that IBD patients have an increased risk of SARS-CoV-2 infection and a worst disease evolution than general population. The primary care practitioner can play a fundamental role in promoting the correct management of the IBD patient during the pandemic spread.","PeriodicalId":48703,"journal":{"name":"Primary Health Care Research and Development","volume":"15 1","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary Health Care Research and Development","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15761/HPC.1000201","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: The Covid-19 epidemic started in late 2019 from China. Since then, it has spread all over the world. SARS-CoV-2 infection poses a new challenge for the health systems of the countries involved, which have diverted all efforts to contain the pandemic spread, penalizing the management of patients with chronic diseases. Also, the activity of IBD units was limited and restricted to severe patients to avoid virus spreading. Aim: The aim of the present review is to summarize and to report the earliest evidence regarding the novel managing strategies for IBD patients, in primary care. Method: A review of the main database of scientific publications was conducted, regarding Covid-19 and the management of the patient with IBD in primary care. Results: Several strategies have proven their efficacy. Among these, the most promising are telehealth and patient education (“shielding education”). These two interventions can monitor safely patient’s health and reduce the infection risk in IBD patient. Discussion: Nowadays, limited data in present scientific literature does not show that IBD patients have an increased risk of SARS-CoV-2 infection and a worst disease evolution than general population. The primary care practitioner can play a fundamental role in promoting the correct management of the IBD patient during the pandemic spread.

查看原文本刊更多论文

初级保健医生(PCP)在管理炎症性肠病(IBD)患者中的作用

新冠肺炎疫情于2019年底从中国开始。从那时起，它已经传播到世界各地。SARS-CoV-2感染给相关国家的卫生系统带来了新的挑战，这些国家转移了所有遏制大流行传播的努力，惩罚了慢性病患者的管理。此外，IBD单位的活性受到限制，并且仅限于重症患者，以避免病毒传播。目的:本综述的目的是总结和报告关于IBD患者在初级保健中的新管理策略的最早证据。方法:检索主要科学出版物数据库，对新冠肺炎和IBD患者的初级保健管理进行综述。结果:几种策略已证明其有效性。其中，最有希望的是远程保健和病人教育("屏蔽教育")。这两种干预措施可以安全地监测患者的健康状况，降低IBD患者的感染风险。讨论:目前，现有科学文献有限的数据并未显示IBD患者感染SARS-CoV-2的风险比一般人群高，疾病演变程度比一般人群差。在大流行传播期间，初级保健医生可以在促进IBD患者的正确管理方面发挥根本作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Primary Health Care Research and Development PRIMARY HEALTH CARE-

CiteScore

2.60

自引率

6.20%

发文量

119

审稿时长

33 weeks

期刊介绍： Primary Health Care Research & Development is aimed specifically at both researchers and practitioners in primary health care, bridging the gap between the two areas. It provides a forum for the publication of international, interdisciplinary research and development in primary health care. It is essential reading for all involved in primary care: nurse practitioners, GPs and health service managers; professional and local groups in community health; researchers and academics; purchasers of primary health care services; allied health practitioners in secondary services and health-related consumer groups.